Suppr超能文献

相似文献

1
Antiviral treatment of hepatitis C.
BMJ. 2014 Jul 7;348:g3308. doi: 10.1136/bmj.g3308.
7
Treatment of hepatitis C virus genotype 3-infection.
Liver Int. 2014 Feb;34 Suppl 1:18-23. doi: 10.1111/liv.12405.
8
Antiviral Therapy in Patients with Hepatitis C Virus-Induced Cirrhosis.
Dig Dis. 2015;33(4):613-23. doi: 10.1159/000375359. Epub 2015 Jul 6.
9
Emerging treatments for hepatitis C.
Expert Opin Emerg Drugs. 2013 Dec;18(4):461-75. doi: 10.1517/14728214.2013.847089. Epub 2013 Oct 8.
10
HCV direct-acting antiviral agents: the best interferon-free combinations.
Liver Int. 2014 Feb;34 Suppl 1(Suppl 1):69-78. doi: 10.1111/liv.12423.

引用本文的文献

4
Risk factors and outcome of hepatitis C infection among patients in a secondary care hospital: A 5-year retrospective study.
J Educ Health Promot. 2024 Jul 11;13:208. doi: 10.4103/jehp.jehp_1326_23. eCollection 2024.
5
9
Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches.
World J Gastroenterol. 2022 Jun 14;28(22):2417-2428. doi: 10.3748/wjg.v28.i22.2417.

本文引用的文献

1
Sofosbuvir and ribavirin in HCV genotypes 2 and 3.
N Engl J Med. 2014 May 22;370(21):1993-2001. doi: 10.1056/NEJMoa1316145. Epub 2014 May 4.
2
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.
N Engl J Med. 2014 May 22;370(21):1983-92. doi: 10.1056/NEJMoa1402338. Epub 2014 May 4.
3
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.
N Engl J Med. 2014 May 15;370(20):1889-98. doi: 10.1056/NEJMoa1402454. Epub 2014 Apr 11.
4
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.
N Engl J Med. 2014 Apr 17;370(16):1483-93. doi: 10.1056/NEJMoa1316366. Epub 2014 Apr 11.
5
ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis.
N Engl J Med. 2014 May 22;370(21):1973-82. doi: 10.1056/NEJMoa1402869. Epub 2014 Apr 11.
6
Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.
N Engl J Med. 2014 Apr 24;370(17):1594-603. doi: 10.1056/NEJMoa1315722. Epub 2014 Apr 10.
7
Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.
N Engl J Med. 2014 Apr 24;370(17):1604-14. doi: 10.1056/NEJMoa1401561. Epub 2014 Apr 10.
8
Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders.
J Hepatol. 2014 Mar;60(3):490-9. doi: 10.1016/j.jhep.2013.10.019. Epub 2013 Oct 26.
9
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.
N Engl J Med. 2014 Jan 16;370(3):211-21. doi: 10.1056/NEJMoa1306218.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验